Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium
Clinical trial NCT02072928 · COMPLETED
Trial details
- NCT number
- NCT02072928
- Sponsor
- Allergan
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-01-28
- Primary completion
- 2015-09-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.